-
A decade of cancer immunotherapy: Keytruda, Opdivo and the drugs that changed oncology
04 Sep 2024 16:23 GMT
… forward into clinical research.
Medarex was in a hurry. … who helped shepherd immunotherapy research while at Medarex and later Bristol … Myers partnered with Medarex to work on immunotherapy research that … trials. Because of its Medarex buyout, Bristol Myers had …
-
Oxford BioTherapeutics Relocates UK Headquarters to Strategic and Cutting-Edge R&D Location at The Oxford Science Park to Accelerate Development of its Immuno-Oncology and ADC-Based Cancer Therapies
11 Oct 2023 08:00 GMT
… overexpressed. Infiltration of tumors by immunosuppressive cells correlates with adverse outcomes … partnerships including with Boehringer Ingelheim, ImmunoGen, Genmab, Agenus and our … development (such as Amgen, WuXi, Medarex (BMS), Alere (Abbott) and BioWa …
-
Regeneron: Growth Plans In Immuno-Oncology (ASCO Update)
08 Jun 2020 12:24 GMT
… that cloak them from immune surveillance. Designing and constructing … at a company called Medarex. And after its acquisition … immunotherapy to the next level.
Unpacking the above: Medarex … intellectual property associated with Medarex and Opdivo is bringing …
-
Biond Biologics Appoints Immunotherapy Pioneer Alan Korman Ph.D. to Scientific Advisory Board
25 Nov 2019 12:00 GMT
… immunotherapy. Prior to BMS, he held various positions at Medarex. … tenures at BMS and Medarex, he was closely … of newly discovered immune-checkpoints and immune-evasion mechanisms. Biond … lead to impairment of immune cell proliferation, differentiation, …
-
UC Berkeley research led to Nobel Prize-winning immunotherapy
01 Oct 2018 09:52 GMT
… Raulet, director of Berkeley’s Immunotherapeutics and Vaccine Research Initiative (IVRI … .
“The temporary activation of the immune system though ‘checkpoint blockade’ provides … with a biotech firm called Medarex, developed human antibodies that showed …
-
Nobel Medicine Prize Honors Cancer Immunotherapy Pioneers Allison & Honjo
01 Oct 2018 15:28 GMT
… founding researchers of the cancer immunotherapy field would win the … these proteins could unleash the immune system on tumors.
Allison, … at a small company called Medarex, which developed an anti- … Honjo helped launched the huge immuno-oncology field of drug …
-
7 Hills Pharma Announces Scientific Advisory Board Formed With Prominent Immuno-Oncology Experts to Help Advance Novel Integrin Activator Program
26 Jun 2018 12:00 GMT
… an experienced pharmaceutical executive and immunologist. He has published numerous … championed immunotherapy at Bristol-Myers Squibb, resulting in the acquisition of Medarex … , Inc. in 2009 and its portfolio of immune therapeutics …
-
T-Cell Immunotherapy Market, 2030 - Competitive Landscape Features a Mix of Established Players and Start-ups, with Academic Institutes Spearheading Early-stage Development Activities
08 Jun 2018 14:00 GMT
… Therapeutics
Immatics Biotechnologies
Immunocore
Immune Therapeutics
Immunovative Therapies
Imperial College … MD Anderson Cancer Center
Medarex
Medical College of Wisconsin … University
Yale University
Zelluna Immunotherapy
Zhejiang Huahai Pharmaceutical
…
-
CRISPR Therapeutics Announces the Appointment of Jon Terrett, Ph.D. to Head of Immuno-Oncology Research and Translation
28 Feb 2017 13:00 GMT
… extensive experience in immuno-oncology
Dedicated unit in immuno-oncology to accelerate … CRISPR to head up our immuno-oncology efforts,” commented Rodger Novak … at various biotechnology companies including Medarex, CellTech and Oxford Glycosciences. Dr …
-
T-Cell Immunotherapy Market, 2030: Post the Early Success of Immune Checkpoint Inhibitors, T-Cell Immunotherapy has Emerged as Another Innovative and Potent Arm of this Market
14 Feb 2017 15:08 GMT
… future potential of T-cell immunotherapies. Immuno-oncology has been gradually … Immatics
- Immune Therapeutics
- Immunex
- ImmunoCellular Therapeutics
- Immunocore
- Immunovative Therapies
- … - MedPost Urgent Care
- Medarex
- Medicxi Ventures
- Medigene …
About
© 1995-2025